---
document_datetime: 2023-09-21 19:54:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/varuby-epar-all-authorised-presentations_en.pdf
document_name: varuby-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6900878
conversion_datetime: 2025-12-20 12:03:59.070343
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of administration   | Immediate Packaging      | Pack size                 |
|------------------|-------------------|------------|-----------------------|---------------------------|--------------------------|---------------------------|
| EU/1/17/1180/001 | Varuby            | 90 mg      | Film-coated tablet    | Oral use                  | blister (alu/PVC/PCT FE) | 1 x 2 tablets (unit dose) |

<!-- image -->